Farabi Pharmaceutical (XTEH:DFRB1) OCF Margin %: 0.00% (As of . 20)


What is Farabi Pharmaceutical OCF Margin %?

Farabi Pharmaceutical XTEH:DFRB1 OCF Margin % is 0.00% as of . 20.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Farabi Pharmaceutical's Cash Flow from Operations for the three months ended in . 20 was IRR0.00 Mil. Farabi Pharmaceutical's Revenue for the three months ended in . 20 was IRR0.00 Mil. Therefore, Farabi Pharmaceutical's OCF Margin % for the quarter that ended in . 20 was 0.00%.

As of today, Farabi Pharmaceutical's current OCF Yield % is 0.00%.

The historical rank and industry rank for Farabi Pharmaceutical's OCF Margin % or its related term are showing as below:


XTEH:DFRB1's OCF Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 9.94
* Ranked among companies with meaningful OCF Margin % only.

Farabi Pharmaceutical OCF Margin % Related Terms

Farabi Pharmaceutical OCF Margin % Historical Data

* Premium members only.

The historical data trend for Farabi Pharmaceutical's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Farabi Pharmaceutical OCF Margin % Chart

Farabi Pharmaceutical Annual Data
Trend
OCF Margin %

Farabi Pharmaceutical Quarterly Data
OCF Margin %

Farabi Pharmaceutical OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Farabi Pharmaceutical's OCF Margin for the fiscal year that ended in . 20 is calculated as

OCF Margin=Cash Flow from Operations (A: . 20 )/Revenue (A: . 20 )
=/
= %

Farabi Pharmaceutical's OCF Margin for the quarter that ended in . 20 is calculated as

OCF Margin=Cash Flow from Operations (Q: . 20 )/Revenue (Q: . 20 )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
Farabi Pharmaceutical (XTEH:DFRB1) has a OCF Margin % of 0.00% as of . 20. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Farabi Pharmaceutical and its competitors.
Is Farabi Pharmaceutical's OCF Margin % too high?
Farabi Pharmaceutical's current OCF Margin % is 0.00%.
How does Farabi Pharmaceutical's OCF Margin % compare to IMNPQ and INNV?
Farabi Pharmaceutical's OCF Margin % of 0.00% can be compared against companies in the Drug Manufacturers industry. The industry median OCF Margin % is 9.94. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.94, based on 961 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Farabi Pharmaceutical and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Farabi Pharmaceutical's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Farabi Pharmaceutical stock overvalued right now?
Farabi Pharmaceutical (XTEH:DFRB1) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Farabi Pharmaceutical (XTEH:DFRB1), the current OCF Margin % is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Farabi Pharmaceutical Business Description

Address South Kheradmand, No. 45, First Floor, Tehran, IRN, 1584853114
Farabi Pharmaceutical is a pharmaceutical company based in Iran. It produces various oral antibiotic-related and non-antibiotic products and dietary supplements. The company develops anti-migraine, antivirals, cholesterol, diabetic, cardiovascular, gastrointestinal, neuroleptics, anti-prostatic and anti-inflammatory and pain release drugs. It offers products in the form of tablet, capsule and suspensions which include Amoxicillin, Cefixime, Azithromycin, Ciprofloxacin, Nitroglycerin, Repaglinide, Orlistat, Domperidone, among others.